You have no idea. There may be serious developments in the background because of that presentation and that may have been why she went ahead with it. No one knows.
Dr. Steven Brem’s group at U. Penn will present an additional dimension of efficacy in June. He’s talking specifically about this trial. It has to do with internal controls — which to me is code for something related to tumor response/reaction. (Or possibly some other radiological signature.) Do people think he’s blowing smoke up people’s a__? I don’t.
Do we know where they are presenting? Or is it also a journal?